Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v3.10.0.1
Segment Disclosures
 9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Segment Disclosures
Segment Disclosures
 
The Company has three reportable segments: Medical Devices, Industrial Sales, and Engineering Services. The Medical Devices segment designs and engineers technology for, and commercializes, manufactures, and sells exoskeletons for applications in the medical markets. The Industrial Sales segment designs, engineers, commercializes, manufactures, and sells exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as the National Science Foundation and the Defense Advanced Research Projects Agency.
 
The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the others manufacture and distribute unique products. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
 
Device and Related
 
Engineering
 
 
 
Medical
 
Industrial
 
Total
 
Services
 
Total
Three months ended September 30, 2018
 

 
 

 
 

 
 

 
 

Revenue
$
1,744

 
$
789

 
$
2,533

 
$
17

 
$
2,550

Cost of revenue
827

 
618

 
1,445

 
22

 
1,467

Gross profit
$
917

 
$
171

 
$
1,088

 
$
(5
)
 
$
1,083

 
 
 
 
 
 
 
 
 
 
Three months ended September 30, 2017
 

 
 

 
 

 
 

 
 

Revenue
$
1,320

 
$
267

 
$
1,587

 
$
10

 
$
1,597

Cost of revenue
880

 
165

 
1,045

 
8

 
1,053

Gross profit
$
440

 
$
102

 
$
542

 
$
18

 
$
544

 
 
Device and Related
 
Engineering
 
 
 
Medical
 
Industrial
 
Total
 
Services
 
Total
Nine months ended September 30, 2018
 

 
 

 
 

 
 

 
 

Revenue
$
6,266

 
$
1,742

 
$
8,008

 
$
28

 
$
8,036

Cost of revenue
3,699

 
1,483

 
5,182

 
35

 
5,217

Gross profit
$
2,567

 
$
259

 
$
2,826

 
$
(7
)
 
$
2,819

 
 
 
 
 
 
 
 
 
 
Nine months ended September 30, 2017
 

 
 

 
 

 
 

 
 

Revenue
$
3,692

 
$
1,170

 
$
4,862

 
$
38

 
$
4,900

Cost of revenue
2,786

 
807

 
3,593

 
15

 
3,608

Gross profit
$
906

 
$
363

 
$
1,269

 
$
23

 
$
1,292


 
Geographic information for revenue based on location of customers is as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
United States
$
1,845

 
$
1,130

 
$
4,976

 
$
3,092

All Other
705

 
467

 
3,060

 
1,808

 
$
2,550

 
$
1,597

 
$
8,036

 
$
4,900